Previous research results indicate that thyroid cancer with intraglandular dissemination has a higher likelihood of lymph node metastasis, higher rates of capsule invasion, higher rates of vascular invasion, and a greater likelihood of BRAF V600E mutation. The gene discussed is BRAF; the disease is thyroid gland carcinoma.